Osteoporosis Treatment Benefits for Individuals Over 80 Years Old
New research suggests that osteoporosis treatment for individuals over 80 who suffer fractures can significantly reduce hospitalization and mortality, emphasizing the importance of personalized care in aging populations.
Recent research presented at ENDO 2025, the annual meeting of the Endocrine Society in San Francisco, highlights the importance of considering osteoporosis treatment for individuals over the age of 80 following a fracture. As the global population ages, the burden of osteoporosis-related complications such as fractures, disability, and mortality continues to rise, underscoring the need for targeted intervention in this vulnerable age group.
Gianina Flocco, M.D., a resident at the Cleveland Clinic, emphasized that initiating osteoporosis therapy after a fracture can significantly reduce hospitalization rates and decrease overall mortality among the elderly. Her team utilized the TriNextX health database to analyze 88,676 patients aged 80 and above who suffered osteoporotic fractures. Patients were divided into those who received osteoporosis medications—such as bisphosphonates, denosumab, raloxifene, or teriparatide—and those who did not receive any treatment.
The study monitored these patients over five years, adjusting for common comorbidities—including hypertension, diabetes, ischemic heart disease, obesity, heart failure, stroke, chronic kidney disease, hyperlipidemia, rheumatoid arthritis, neoplasms, and vitamin D deficiency. Results showed that patients on osteoporosis treatment experienced a lower risk of hospitalization and a reduction in all-cause mortality, demonstrating the benefits of proactive treatment in this age group.
Flocco pointed out that the increasing prevalence of osteoporosis with aging necessitates personalized treatment strategies. She advocates for extending osteoporosis therapy to the most vulnerable older adults to prevent fractures and associated disabilities, ultimately improving health span.
The findings reinforce the importance of healthcare providers considering osteoporosis management in the very elderly, especially after fractures, to mitigate future risks and enhance quality of life for this growing demographic.
Source: https://medicalxpress.com/news/2025-07-osteoporosis-treatment-benefit-people-older.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
High Birth Weight Identified as Key Risk Factor for Serious Birth Injuries
New study finds high birth weight is a major risk factor for obstetric anal sphincter injuries, leading to long-term health impacts. Predictive models aim to improve childbirth safety.
Rivaroxaban Demonstrates Safety and Effectiveness for Long-Term Use in Children with Venous Thromboembolism
Recent long-term studies confirm that rivaroxaban is a safe and effective option for extended treatment of venous thromboembolism in children, offering a scientifically supported alternative to traditional therapies.
West Coast States Establish New Agency to Lead Vaccine Guidelines Amid Political Tensions
California, Washington, and Oregon announced the creation of the West Coast Health Alliance to develop vaccine guidelines independently amid concerns over politicization and federal disruptions at the CDC.
First U.S. Case of New World Screwworm Parasite Linked to Travel to Central America
A rare case of the New World screwworm parasite has been confirmed in the U.S., marking the first travel-related infection linked to an outbreak in Central America. Experts emphasize vigilance as authorities work to prevent further spread.